JP2014207874A - 肌の色調改善剤のスクリーニング法 - Google Patents
肌の色調改善剤のスクリーニング法 Download PDFInfo
- Publication number
- JP2014207874A JP2014207874A JP2013182698A JP2013182698A JP2014207874A JP 2014207874 A JP2014207874 A JP 2014207874A JP 2013182698 A JP2013182698 A JP 2013182698A JP 2013182698 A JP2013182698 A JP 2013182698A JP 2014207874 A JP2014207874 A JP 2014207874A
- Authority
- JP
- Japan
- Prior art keywords
- vamp
- skin
- expression level
- related factor
- test substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 50
- 238000012216 screening Methods 0.000 title claims abstract description 25
- 230000003834 intracellular effect Effects 0.000 claims abstract description 39
- 230000004069 differentiation Effects 0.000 claims abstract description 37
- 230000000694 effects Effects 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 31
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 128
- 230000014509 gene expression Effects 0.000 claims description 61
- 108090000623 proteins and genes Proteins 0.000 claims description 57
- 239000000126 substance Substances 0.000 claims description 51
- 238000012360 testing method Methods 0.000 claims description 43
- 230000028973 vesicle-mediated transport Effects 0.000 claims description 35
- 108010017743 Vesicle-Associated Membrane Protein 1 Proteins 0.000 claims description 26
- 102100037105 Vesicle-associated membrane protein 1 Human genes 0.000 claims description 26
- 230000009471 action Effects 0.000 claims description 25
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 230000002087 whitening effect Effects 0.000 claims description 16
- -1 kerati. n 5 Proteins 0.000 claims description 15
- 102100023970 Keratin, type I cytoskeletal 10 Human genes 0.000 claims description 10
- 108010065038 Keratin-10 Proteins 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 108010010469 Qa-SNARE Proteins Proteins 0.000 claims description 6
- 102000004243 Tubulin Human genes 0.000 claims description 6
- 108090000704 Tubulin Proteins 0.000 claims description 6
- 108010017749 Vesicle-Associated Membrane Protein 3 Proteins 0.000 claims description 6
- 102000003786 Vesicle-associated membrane protein 2 Human genes 0.000 claims description 6
- 108090000169 Vesicle-associated membrane protein 2 Proteins 0.000 claims description 6
- 102100031486 Vesicle-associated membrane protein 3 Human genes 0.000 claims description 6
- 102100036499 Vesicle-associated membrane protein 7 Human genes 0.000 claims description 6
- 102100036505 Vesicle-associated membrane protein 8 Human genes 0.000 claims description 6
- 101710205049 Vesicle-associated membrane protein 8 Proteins 0.000 claims description 6
- 239000002537 cosmetic Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 102000015799 Qa-SNARE Proteins Human genes 0.000 claims description 5
- 101150046023 SEC22B gene Proteins 0.000 claims description 5
- 102100031489 Vesicle-associated membrane protein 4 Human genes 0.000 claims description 5
- 108091013883 Vesicle-associated membrane protein 4 Proteins 0.000 claims description 5
- 101710205051 Vesicle-associated membrane protein 7 Proteins 0.000 claims description 5
- 101150016810 YKT6 gene Proteins 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 102000005708 Desmoglein 1 Human genes 0.000 claims description 4
- 108010045579 Desmoglein 1 Proteins 0.000 claims description 4
- 102000005707 Desmoglein 2 Human genes 0.000 claims description 4
- 108010045583 Desmoglein 2 Proteins 0.000 claims description 4
- 102000007577 Desmoglein 3 Human genes 0.000 claims description 4
- 108010032035 Desmoglein 3 Proteins 0.000 claims description 4
- 102100028314 Filaggrin Human genes 0.000 claims description 4
- 101710088660 Filaggrin Proteins 0.000 claims description 4
- 101001046532 Homo sapiens Kinesin-like protein KIFC3 Proteins 0.000 claims description 4
- 101000742002 Homo sapiens Prickle-like protein 1 Proteins 0.000 claims description 4
- 101001091773 Homo sapiens Rab-interacting lysosomal protein Proteins 0.000 claims description 4
- 102100040445 Keratin, type I cytoskeletal 14 Human genes 0.000 claims description 4
- 102100022905 Keratin, type II cytoskeletal 1 Human genes 0.000 claims description 4
- 108010070514 Keratin-1 Proteins 0.000 claims description 4
- 108010066321 Keratin-14 Proteins 0.000 claims description 4
- 102100023422 Kinesin-1 heavy chain Human genes 0.000 claims description 4
- 102100022250 Kinesin-like protein KIFC3 Human genes 0.000 claims description 4
- 102100031784 Loricrin Human genes 0.000 claims description 4
- 101150030875 RAB7A gene Proteins 0.000 claims description 4
- 102100035836 Rab-interacting lysosomal protein Human genes 0.000 claims description 4
- 102000007236 involucrin Human genes 0.000 claims description 4
- 108010033564 involucrin Proteins 0.000 claims description 4
- 108010079309 loricrin Proteins 0.000 claims description 4
- 108090000663 Annexin A1 Proteins 0.000 claims description 3
- 102100040006 Annexin A1 Human genes 0.000 claims description 3
- 102100034613 Annexin A2 Human genes 0.000 claims description 3
- 108090000668 Annexin A2 Proteins 0.000 claims description 3
- 102100038612 Calmodulin-regulated spectrin-associated protein 3 Human genes 0.000 claims description 3
- 101000741294 Homo sapiens Calmodulin-regulated spectrin-associated protein 3 Proteins 0.000 claims description 3
- 101001126081 Homo sapiens Pleckstrin homology domain-containing family A member 7 Proteins 0.000 claims description 3
- 108010028299 Myosin Type V Proteins 0.000 claims description 3
- 102100036640 Myosin-10 Human genes 0.000 claims description 3
- 101710115163 Myosin-10 Proteins 0.000 claims description 3
- 102100029366 Pleckstrin homology domain-containing family A member 7 Human genes 0.000 claims description 3
- 102100038094 Protein-glutamine gamma-glutamyltransferase E Human genes 0.000 claims description 3
- 101710182788 Protein-glutamine gamma-glutamyltransferase E Proteins 0.000 claims description 3
- 102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 claims description 3
- 102100030545 Synaptosomal-associated protein 23 Human genes 0.000 claims description 3
- 101710189545 Synaptosomal-associated protein 23 Proteins 0.000 claims description 3
- 108010090618 Syntaxin 1 Proteins 0.000 claims description 3
- 102100030409 Unconventional myosin-Va Human genes 0.000 claims description 3
- 208000036815 beta tubulin Diseases 0.000 claims description 3
- 108010058734 transglutaminase 1 Proteins 0.000 claims description 3
- 108091009550 Vesicle-associated membrane protein 5 Proteins 0.000 claims description 2
- 102100031484 Vesicle-associated membrane protein 5 Human genes 0.000 claims description 2
- 101100347613 Caenorhabditis elegans unc-54 gene Proteins 0.000 claims 1
- 102100035936 Syntaxin-2 Human genes 0.000 claims 1
- 102100027975 Syntaxin-4 Human genes 0.000 claims 1
- 230000010534 mechanism of action Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 64
- 210000003491 skin Anatomy 0.000 description 51
- 210000002510 keratinocyte Anatomy 0.000 description 30
- 239000000284 extract Substances 0.000 description 18
- 108020004999 messenger RNA Proteins 0.000 description 17
- 238000009826 distribution Methods 0.000 description 15
- 210000003855 cell nucleus Anatomy 0.000 description 11
- 210000002780 melanosome Anatomy 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 239000003112 inhibitor Substances 0.000 description 8
- 230000007423 decrease Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000013615 primer Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 4
- 230000024245 cell differentiation Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000011530 RNeasy Mini Kit Methods 0.000 description 3
- 108020004459 Small interfering RNA Proteins 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000012096 transfection reagent Substances 0.000 description 3
- ATCJTYORYKLVIA-SRXJVYAUSA-N vamp regimen Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1.C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C(C45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C=O)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 ATCJTYORYKLVIA-SRXJVYAUSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 101000879393 Aplysia californica Synaptobrevin Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 108020001019 DNA Primers Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 102000002045 Endothelin Human genes 0.000 description 2
- 108050009340 Endothelin Proteins 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102100025756 Keratin, type II cytoskeletal 5 Human genes 0.000 description 2
- 108010070553 Keratin-5 Proteins 0.000 description 2
- 102100034751 Kinectin Human genes 0.000 description 2
- 101710205782 Kinectin Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 102000050708 Syntaxin-2 Human genes 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000002247 constant time method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000001787 dendrite Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000011539 homogenization buffer Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940121649 protein inhibitor Drugs 0.000 description 2
- 239000012268 protein inhibitor Substances 0.000 description 2
- 229940126409 proton pump inhibitor Drugs 0.000 description 2
- 239000000612 proton pump inhibitor Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 102000016362 Catenins Human genes 0.000 description 1
- 108010067316 Catenins Proteins 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 240000007058 Halophila ovalis Species 0.000 description 1
- 101000975474 Homo sapiens Keratin, type I cytoskeletal 10 Proteins 0.000 description 1
- 101100263425 Homo sapiens VAMP1 gene Proteins 0.000 description 1
- 101000852166 Homo sapiens Vesicle-associated membrane protein 7 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 229940069638 aloe vera leaf extract Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- 102000013035 dynein heavy chain Human genes 0.000 description 1
- 108060002430 dynein heavy chain Proteins 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940114496 olive leaf extract Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Cosmetics (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Plant Pathology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013182698A JP2014207874A (ja) | 2013-03-28 | 2013-09-04 | 肌の色調改善剤のスクリーニング法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013068663 | 2013-03-28 | ||
| JP2013068663 | 2013-03-28 | ||
| JP2013182698A JP2014207874A (ja) | 2013-03-28 | 2013-09-04 | 肌の色調改善剤のスクリーニング法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017149607A Division JP6460426B2 (ja) | 2013-03-28 | 2017-08-02 | 肌の色調改善剤のスクリーニング法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014207874A true JP2014207874A (ja) | 2014-11-06 |
| JP2014207874A5 JP2014207874A5 (enExample) | 2016-09-08 |
Family
ID=51902632
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013182698A Pending JP2014207874A (ja) | 2013-03-28 | 2013-09-04 | 肌の色調改善剤のスクリーニング法 |
| JP2017149607A Active JP6460426B2 (ja) | 2013-03-28 | 2017-08-02 | 肌の色調改善剤のスクリーニング法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017149607A Active JP6460426B2 (ja) | 2013-03-28 | 2017-08-02 | 肌の色調改善剤のスクリーニング法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP2014207874A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016090455A (ja) * | 2014-11-07 | 2016-05-23 | ポーラ化成工業株式会社 | 多層色素沈着改善剤 |
| JP2016088902A (ja) * | 2014-11-07 | 2016-05-23 | ポーラ化成工業株式会社 | 徐放担体 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6583704B2 (ja) * | 2014-09-25 | 2019-10-02 | ポーラ化成工業株式会社 | 色素沈着改善剤のスクリーニング法 |
| CN108998537A (zh) * | 2018-07-27 | 2018-12-14 | 珠海伊斯佳科技股份有限公司 | 一种基于肤色相关基因检测制定个性化护肤方案的方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007126104A1 (ja) * | 2006-04-25 | 2007-11-08 | Shiseido Company, Ltd. | しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法 |
| JP2009035499A (ja) * | 2007-07-31 | 2009-02-19 | Mandom Corp | Ｅ−セレクチンの発現抑制剤及び美白剤の評価方法 |
| WO2009113446A1 (ja) * | 2008-03-11 | 2009-09-17 | 株式会社資生堂 | 皮膚美白方法、並びに、皮膚シミ形成抑制及び／又は除去因子のスクリーニング方法 |
| JP2009275025A (ja) * | 2008-04-16 | 2009-11-26 | Pierre Fabre Dermo-Cosmetique | 脱色素剤としてのギンバイカエキスの使用 |
| JP2012102049A (ja) * | 2010-11-10 | 2012-05-31 | Nof Corp | 表皮角化細胞賦活剤および皮膚外用剤 |
| JP2012167048A (ja) * | 2011-02-14 | 2012-09-06 | Nitto Best Kk | 表皮角化正常化剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011130751A (ja) * | 2009-12-25 | 2011-07-07 | Kao Corp | 肌色制御因子 |
| KR102072783B1 (ko) * | 2011-04-22 | 2020-02-03 | 로레알 | 세포외 매트릭스와 연관되는, 피부 색소 반점의 분자 지표 |
| US20140044799A1 (en) * | 2011-04-22 | 2014-02-13 | L'oreal | Molecular signature of cutaneous pigmentary spots, associated with the organization of the extracellular matrix |
-
2013
- 2013-09-04 JP JP2013182698A patent/JP2014207874A/ja active Pending
-
2017
- 2017-08-02 JP JP2017149607A patent/JP6460426B2/ja active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007126104A1 (ja) * | 2006-04-25 | 2007-11-08 | Shiseido Company, Ltd. | しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法 |
| JP2009035499A (ja) * | 2007-07-31 | 2009-02-19 | Mandom Corp | Ｅ−セレクチンの発現抑制剤及び美白剤の評価方法 |
| WO2009113446A1 (ja) * | 2008-03-11 | 2009-09-17 | 株式会社資生堂 | 皮膚美白方法、並びに、皮膚シミ形成抑制及び／又は除去因子のスクリーニング方法 |
| JP2009275025A (ja) * | 2008-04-16 | 2009-11-26 | Pierre Fabre Dermo-Cosmetique | 脱色素剤としてのギンバイカエキスの使用 |
| JP2012102049A (ja) * | 2010-11-10 | 2012-05-31 | Nof Corp | 表皮角化細胞賦活剤および皮膚外用剤 |
| JP2012167048A (ja) * | 2011-02-14 | 2012-09-06 | Nitto Best Kk | 表皮角化正常化剤 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016090455A (ja) * | 2014-11-07 | 2016-05-23 | ポーラ化成工業株式会社 | 多層色素沈着改善剤 |
| JP2016088902A (ja) * | 2014-11-07 | 2016-05-23 | ポーラ化成工業株式会社 | 徐放担体 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017195901A (ja) | 2017-11-02 |
| JP6460426B2 (ja) | 2019-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6460426B2 (ja) | 肌の色調改善剤のスクリーニング法 | |
| US10092495B2 (en) | Use of a composition comprising avocado perseose in the protection of epidermal stem cells | |
| KR20130134976A (ko) | 백미 추출물을 함유하는 피부 미백 화장료 조성물 | |
| JP5420669B2 (ja) | 皮膚または毛髪の色素沈着の検討または調節に有用な方法、組成物で使用するための植物抽出物、および化粧的ケアの方法 | |
| JP2015028036A (ja) | Ｌｏｘタンパク質とｎｒａｇｅタンパク質との通常の共発現と相互作用を復元させる物質 | |
| JP5858562B2 (ja) | 琥珀から得られるエンドセリン−１産生抑制剤、ｓｃｆ産生抑制剤、及びメラニン産生抑制剤並びにその使用 | |
| US10172787B2 (en) | Method of regulating a condition of mammalian keratinous tissue | |
| US10537515B2 (en) | Personal care composition and method of making the same | |
| JP6688051B2 (ja) | メラニン産生抑制剤 | |
| US9952201B2 (en) | Method for evaluating the harmful effects of UV on children's skin | |
| WO2012144080A1 (ja) | 皮膚バリア機能改善剤 | |
| JP7497974B2 (ja) | Ｍｐｃ１抑制により皮膚幹細胞を活性化する方法および皮膚幹細胞活性化剤 | |
| Kim et al. | Rice bran mineral extract increases the expression of anagen-related molecules in human dermal papilla through wnt/catenin pathway | |
| CN102498221A (zh) | 基于aff-4表达筛选抗白发剂的方法 | |
| JP6583704B2 (ja) | 色素沈着改善剤のスクリーニング法 | |
| JP2011115152A (ja) | スクリーニング法 | |
| US10196607B2 (en) | Reconstituted nipple skin model | |
| TWI480047B (zh) | 牡丹皮萃取物及其製造方法暨應用 | |
| JP6405194B2 (ja) | 多層色素沈着改善剤 | |
| TWI483742B (zh) | 利用含有牡丹皮萃取物之組成物於體外處理細胞之方法及其應用 | |
| Conlon et al. | Bioactivity of autotrophic and mixotrophic Tetraselmis chuii (CCAP 66/21B) extracts against H2O2-mediated stress in A549 cells. | |
| CN116869867B (zh) | 一种具有ppar激动的天然油脂组合物及其制备方法和用途 | |
| CN107875052B (zh) | 紫笋茶化妆水及其制备方法 | |
| Yamauchi et al. | Skin Transparency Improvement Effects of Rice Vitamin E Crude Extract | |
| Ercal et al. | Osteo/odontogenic differentiation analysis of dental stem cells from tooth germ, apical papilla, and dental follicle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160722 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160722 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170606 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180206 |